VanEck Pharmaceutical ETF
PPH
PPH
41 hedge funds and large institutions have $55.8M invested in VanEck Pharmaceutical ETF in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
74% less call options, than puts
Call options by funds: $1.74M | Put options by funds: $6.77M
Holders
41
Holding in Top 10
–
Calls
$1.74M
Puts
$6.77M
Top Buyers
| 1 | +$8.37M | |
| 2 | +$3.93M | |
| 3 | +$2.28M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.8M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.64M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$1.3M | |
| 3 | -$1.2M | |
| 4 |
FA
Fortis Advisors
Wayne,
Pennsylvania
|
-$763K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$310K |